Literature DB >> 7631703

Antenatal corticosteroid treatment and neonatal outcomes for infants 501 to 1500 gm in the Vermont-Oxford Trials Network.

J D Horbar1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7631703     DOI： 10.1016/0002-9378(95)90213-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  4 in total

Review 1.  Fetal pharmacotherapy.

Authors:  Gideon Koren; Gil Klinger; Arne Ohlsson
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Drug transfer and metabolism by the human placenta.

Authors:  Michael R Syme; James W Paxton; Jeffrey A Keelan
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

3.  Analysis of prenatal and postnatal risk factors of retinopathy of prematurity in a tertiary care hospital in South India.

Authors:  Krishna A Rao; Jayashree Purkayastha; Manali Hazarika; Raghuvamsi Chaitra; K Mithun Adith
Journal:  Indian J Ophthalmol       Date:  2013-11       Impact factor: 1.848

4.  Retinopathy of prematurity: risk factors and role of antenatal betamethasone in Indian preterm newborn babies.

Authors:  Baljeet Maini; Harish Chellani; Sugandha Arya; B P Guliani
Journal:  J Clin Neonatol       Date:  2014-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.